THORATEC CORPORATION (THOR)

Sector:
HEALTH CARE
Industry:
HEALTH CARE
SIC:
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
CEO:
D. Keith Grossman
Employees:
954
6035 STONERIDGE DR, PLEASANTON, CA 94588
9258478600

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Thoratec Corporation, together with its subsidiaries, develops, manufactures, and markets proprietary medical devices used for mechanical circulatory support for the treatment of heart failure patients.

Data derived from most recent annual or quarterly report
Market Cap 3.442 Billion Shares Outstanding54.2 Million Avg 30-day Volume 1.142 Million
P/E Ratio62.9913 Dividend Yield0.0 EPS0.44
Price to Revenue5.0475 Debt to Equity0.0085 EBITDA73.011 Million
Price to Book Value3.5899 Operating Margin11.1974 Enterprise Value2.17 Billion
Current Ratio5.536 EPS Growth-0.393 Quick Ratio4.25
1 Yr BETA 0.4891 52-week High/Low 0.0 / Profit Margin8.013
Operating Cash Flow Growth-7.728 Altman Z-Score12.1415 Free Cash Flow to Firm 23.3 Million

Are you looking for this stock instead?

View SEC Filings from THOR instead.

View recent insider trading info

THORATEC CORPORATION YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding THOR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding THOR

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SHAWVER LAURA PRESIDENT AND CEO

  • Officer
  • Director
 105,706 2019-01-24 0

POWELL ANDREW KENNETH WILLIAM

  • Director
 0 2018-12-19 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VII LLC

  • Director
  • 10% Owner
 0 2018-12-06 0

CAPPS VICKIE L

  • Director
 0 2018-12-06 0

RA CAPITAL MANAGEMENT, LLC

RA CAPITAL HEALTHCARE FUND LP

  • 10% Owner
 0 2018-12-06 0

THOMPSON PETER A.

  • Director
  • 10% Owner
 0 2018-12-06 0

LICHTER JAY

  • Director
  • 10% Owner
 187,237 2018-12-06 0

KOLCHINSKY PETER

  • Director
  • 10% Owner
 0 2018-12-06 0

AVALON VENTURES X, L.P.

AVALON X SPV, L.P.

  • 10% Owner
 187,237 2018-12-06 0

SHAH PRATIK

  • Director
 62,412 2018-12-06 0

LEVEQUE JOSEPH CHIEF MEDICAL OFFICER

  • Officer
 259,365 2018-12-06 0

REARDON TIGHE ACTING CHIEF FINANCIAL OFFICER

  • Officer
 43,688 2018-12-06 0

ROMESBERG FLOYD

  • Director
 280,856 2018-12-06 0

MILLA MARCOS CHIEF SCIENTIFIC OFFICER

  • Officer
 0 2018-12-06 0

HAWKINS WILLIAM A

  • Director
 No longer subject to file 2015-10-08 0

LAVIOLETTE PAUL A

  • Director
 No longer subject to file 2015-10-08 0

COLLIS STEVEN H

  • Director
 No longer subject to file 2015-10-08 0

SCHERMERHORN TODD C

  • Director
 No longer subject to file 2015-10-08 0

COLE J DANIEL

  • Director
 No longer subject to file 2015-10-08 0

GROSSMAN D KEITH PRESIDENT & CHIEF EXEC OFFICER

  • Officer
  • Director
 No longer subject to file 2015-10-08 0

DIMICK NEIL F

  • Director
 No longer subject to file 2015-10-08 0

LEHMAN DAVID AARON SVP AND GENERAL COUNSEL

  • Officer
 No longer subject to file 2015-10-08 0

MARSH MARTHA H.

  • Director
 No longer subject to file 2015-10-08 0

HARRIS TAYLOR C. VP, CHIEF FINANCIAL OFFICER

  • Officer
 No longer subject to file 2015-10-08 0

PADMANABHAN VASANT SVP, TECHNICAL OPERATIONS

  • Officer
 No longer subject to file 2015-10-08 0

PELLEGRINI NIAMH LOUISE PRESIDENT, NORTH AMERICA

  • Officer
 No longer subject to file 2015-10-08 0

ANTONUCCI MARTA PRESIDENT, INTERNATIONAL

  • Officer
 No longer subject to file 2015-10-08 0

BURBACH GERHARD F CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 169,970 2014-03-17 0

MULVENA DANIEL M

  • Director
 18,799 2013-10-31 0

FINNEY ELISHA W

  • Director
 24,284 2013-05-20 0

OULMAN ROXANNE VP OF FINANCE, INTERIM CFO

  • Officer
 26,222 2012-09-06 0

SMITH DAVID V CFO & EVP

  • Officer
 64,591 2011-03-15 0

COHEN LAWRENCE DIVISION PRESIDENT

  • Officer
 32,329 2010-06-10 0

HILL J DONALD

  • Director
 920,208 2009-02-23 0

KELLOGG PETER R

  • LESS THAN 9% OWNER
 4,339,099 2008-11-13 0

CHASE HOWARD E

  • Director
 11,250 2008-08-04 0

HOLBROOK GEORGE W JR

  • Director
 151,591 2007-02-27 0

HITCHCOCK WILLIAM M

  • Director
 804,205 2007-02-20 0

NELSON JEFFREY DIVISION PRESIDENT

  • Officer
 8,422 2007-01-12 0

LUCCHESE CYNTHIA L CHIEF FINANCIAL OFFICER

  • Officer
 22,224 2006-03-31 0

TAYLOR BETH A VP, ADMINISTRATION

  • Officer
 23,335 2006-03-31 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments